Michael West

Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling

A. D. Rodrigues, S. Yamazaki, M. Varma, 2021, CPT: pharmacometrics & systems pharmacology.

Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

S. M. Owens, F. Carroll, E. Laurenzana, 2009, Vaccine.

The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide–Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy

A. Kalgutkar, L. Di, B. Feng, 2016, Drug Metabolism and Disposition.

Optimizing Higher Throughput Methods to Assess Drug-Drug Interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 In Vitro Using a Single Point IC50

Sean Ekins, John Janiszewski, R. D. Meyer, 2002, Journal of biomolecular screening.

Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs

G. S. Walker, R. Obach, R. Walsky, 2012, Drug Metabolism and Disposition.

Drug–Drug Interactions: Screening for Liability and Assessment of Risk

R. Obach, K. Youdim, M. Wester, 2009 .

Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition.

Sean Ekins, Ying Jiang, Michael West, 2010, Chemical research in toxicology.

The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide–Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy

A. Kalgutkar, L. Di, B. Feng, 2016, Drug Metabolism and Disposition.